Akin to NK cells, NKG2D activation prompts γδ T cells to release cytolytic granules, leading to in vitro cytotoxic activity against various tumor cell types, including those derived from CRC, SCC, and human renal cell carcinoma [1, 22, 36, 37, 84]. This evidence concerns the gene KLRK1 and colorectal carcinoma.